Paid Clinical Trials Stamford

Discover 1,018 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,018

Endometriosis and Microvascular Dysfunction; Simvastatin and DuaveeEndometriosis and Microvascular Dysfunction; Simvastatin and Duavee

Recruiting

Sponsor:

Penn State University

Location:

New Haven CT

Code:

NCT05059626

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

simvastatin 10mg

Bazedoxifene 20/Estrogens,Con 0.45Mg Tb

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass SurgeryEffect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Recruiting

Sponsor:

Unity Health Toronto

Location:

New Haven CT, Portland ME, Kingston, Torontoshow 5 more

Code:

NCT03900026

Conditions

Coronary Artery Bypass Graft Surgery

Atherosclerosis

Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evolocumab

Placebo

A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Recruiting

PHASE3

Sponsor:

Boston Children's Hospital

Location:

New Hyde Park NY, Hackensack NJ, New York NY, New Haven CTshow 43 more

Code:

NCT05600426

Conditions

Severe Aplastic Anemia

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

cyclosporine

Matched Unrelated Donor Hematopoetic Stem Cell Transplant

horse anti-thymocyte globulin (ATG)

rabbit anti-thymocyte globulin (ATG)

Methotrexate

Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast CancerPhase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Ellipses Pharma

Location:

New Haven CT, Boston MA, Fairfax VA, Detroit MIshow 3 more

Code:

NCT05573126

Conditions

Hormone Receptor-positive Breast Cancer

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vosilasarm

Elacestrant

Everolimus

Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette UseConcurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

Recruiting

PHASE1

Sponsor:

Yale University

Location:

New Haven CT

Code:

NCT06027840

Conditions

Cigarette Smoking

E-Cigarette Use

Smoking Cessation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Varenicline

Counseling

Guided Self-Change Booklets

Longitudinal Neural Fingerprinting of Opioid-use TrajectoriesLongitudinal Neural Fingerprinting of Opioid-use Trajectories

Recruiting

Sponsor:

Yale University

Location:

New Haven CT

Code:

NCT06207162

Conditions

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

fMRI

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting

PHASE3

Sponsor:

Chimerix

Location:

Fairfield CT, New York NY, Summit NJ, Neptune NJshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

DALY II USA/ MB-CART2019.1 for DLBCLDALY II USA/ MB-CART2019.1 for DLBCL

Recruiting

PHASE2

Sponsor:

Miltenyi Biomedicine GmbH

Location:

New York NY, New Haven CT, Boston MA, Baltimore MDshow 18 more

Code:

NCT04792489

Conditions

Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Relapsed Diffuse Large B Cell Lymphoma

High Grade B-cell Lymphoma (HGBCL)

Primary Mediastinal B-cell Lymphoma (PMBCL)

Transformed Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zamtocabtagene autoleucel (MB-CART2019.1)

Cyclophosphamide

Fludarabine

Bendamustine

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting

Sponsor:

Theratechnologies

Location:

Stamford CT, New Haven CT, Newark NJ, Waterbury CTshow 21 more

Code:

NCT05388474

Conditions

HIV Infections

Multi-Antiviral Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No ibalizumab or Pre-ibalizumab treatment

On ibalizumab treatment

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C MutationA Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

Recruiting

PHASE1

Sponsor:

Genentech, Inc.

Location:

New York NY, New Haven CT, Philadelphia PA, Boston MAshow 10 more

Code:

NCT04449874

Conditions

Non-Small Cell Lung Cancer

Colorectal Cancer

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GDC-6036

Atezolizumab

Cetuximab

Bevacizumab

Erlotinib